Monday, January 21, 2008

Therapeutic Options

sildenafil (Sildenafil) and Levitra (Vardenafil) is effective in patients with organic (neurogenic, vasculogenic) or psychogenic erectile dysfunction and in those whose erectile dysfunction is of mixed cause.
viagra (Sildenafil) and Levitra (Vardenafil) also has been effective in counteracting drug-induced erectile dysfunction.
The goal of such therapy is to compare an sexual arousal of adequate rigidness and temporal property to be sexually functional and that is satisfying to the semantic role and his better half, and the main condition payment is improved tone of life.
With the availability of orally soul and convenient vasoactive (erectogenic) therapies (e.g., selective PDE type 5 inhibitors such as viagra (Sildenafil) and Levitra (Vardenafil), vardenafil, tadalafil), most experts now consider these drugs, part narrowing devices, and/or psychosexual therapy to be suitable first-line therapies for a broad potentiality of patients with erectile dysfunction.
Second-line therapy may be considered for patients who fail to respond to, or are not candidates for, first-line therapy (e.g., patients who require nitrate therapy).
Intracavernosal or intraurethral vasoactive therapy generally is considered a second-line alternative.
Vasoactive therapy or vacuity compressing devices generally are considered or attempted before resorting to more invasive (e.g., surgical) therapies.
viagra (Sildenafil) and Levitra (Vardenafil) also has been effective in a limited telephone number of men with temporary erectile dysfunction associated with the inflection of comparing a sperm instance (e.g., for intrauterine activity or in vitro impregnation during assisted reproduction).
In men with a past times of such temporary dysfunction, planned use of viagra (Sildenafil) and Levitra (Vardenafil) for subsequent attempts at obtaining a sperm example may improve acquisition of an structure adequate for self-stimulated exclaiming.
This is a part of article Therapeutic Options Taken from "Sildenafil Citrate India" Information Blog

No comments: